An investment in HumaTerra™ is an investment in future yields.
Quarter section barley trials in 2022 – 40 acres per treatment. Yield and root biomass (left axis) increase after 2 consecutive years of treatment with HumaTerra bioinoculants.
We have invested in Research and Development (R&D) to test our products continuously. HumaTerra has recurrent perennial third-party trials across 10 research stations (six in Alberta and four in Saskatchewan) and ongoing head-to-head commercial trials in Alberta and Saskatchewan.
Contact us today to learn more.